MassMutual Private Wealth & Trust’s Vanda Pharmaceuticals VNDA Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-451	Closed	-$2.07K	–	2497
2025 Q1	$2.07K	Hold	451	–	–	﹤0.01%	1908
2024 Q4	$2.16K	Sell	451 -72	-14%	-$346	﹤0.01%	1816
2024 Q3	$2.45K	Buy	523 +156	+43%	+$836	﹤0.01%	1599
2024 Q2	$2.07K	Hold	367	–	–	﹤0.01%	1622
2024 Q1	$1.51K	Hold	367	–	–	﹤0.01%	1613
2023 Q4	$1.55K	Sell	367 -68	-16%	-$274	﹤0.01%	1587
2023 Q3	$1.88K	Sell	435 -574	-57%	-$3.19K	﹤0.01%	1518
2023 Q2	$6.65K	Buy	+1,009	New	+$6.47K	﹤0.01%	1109
2022 Q4	–	Sell	-85	Closed	-$1K	–	1871
2022 Q3	$1K	Buy	+85	New	+$897	﹤0.01%	1554
2022 Q1	–	Sell	-36	Closed	-$1K	–	1646
2021 Q4	$1K	Buy	+36	New	+$627	﹤0.01%	1326

Other funds holding VNDA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

MassMutual Private Wealth & Trust's VNDA Position: Q2 2025 in Review

MassMutual Private Wealth & Trust sold out of Vanda Pharmaceuticals (VNDA) in Q2 2025, closing a stake of 451 shares — an estimated $2.07K sold.

MassMutual Private Wealth & Trust first reported a position in VNDA in Q4 2021 and held it in 10 quarters. The position peaked at $6.65K in Q2 2023. 139 funds tracked by Wall St. Rank hold VNDA as of Q2 2025.

MassMutual Private Wealth & Trust reported no remaining Vanda Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
MassMutual Private Wealth & Trust sold 451 Vanda Pharmaceuticals shares in Q2 2025, an estimated $2.07K.
MassMutual Private Wealth & Trust first reported a position in Vanda Pharmaceuticals in Q4 2021 and held it in 10 quarters.
MassMutual Private Wealth & Trust's Vanda Pharmaceuticals position peaked at $6.65K in Q2 2023.
139 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2025.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2025, filed 9 Jul 2025.